DelSiTech Enters into an Exclusive Licensing Agreement with Optifye Therapeutics for the Development of a Controlled Release Ophthalmic Eye Drop Product
/PRNewswire/ -- DelSiTech Ltd, the leading silica drug delivery technology company, based in Finland and Optifye Therapeutics AG, a Swiss-based pharmaceutical...
Lasse Leino Janos Vaczi Delsitech Ltd Optifye Therapeutics Silica Matrix Managing Directorof Optifye Therapeutics
Source: prnewswire.com